Free Trial

Sanctuary Advisors LLC Makes New $864,000 Investment in Tiziana Life Sciences Ltd (NASDAQ:TLSA)

Tiziana Life Sciences logo with Medical background

Sanctuary Advisors LLC acquired a new stake in shares of Tiziana Life Sciences Ltd (NASDAQ:TLSA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 907,613 shares of the company's stock, valued at approximately $864,000. Sanctuary Advisors LLC owned approximately 0.86% of Tiziana Life Sciences at the end of the most recent reporting period.

Separately, Zhang Financial LLC increased its holdings in Tiziana Life Sciences by 24.2% during the 3rd quarter. Zhang Financial LLC now owns 69,387 shares of the company's stock worth $67,000 after purchasing an additional 13,500 shares during the period.

Tiziana Life Sciences Stock Down 12.1 %

NASDAQ:TLSA traded down $0.09 during mid-day trading on Monday, reaching $0.68. The company's stock had a trading volume of 753,935 shares, compared to its average volume of 225,533. The stock has a fifty day moving average of $0.95 and a 200-day moving average of $0.97. Tiziana Life Sciences Ltd has a 1 year low of $0.41 and a 1 year high of $1.74.

Tiziana Life Sciences Profile

(Free Report)

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.

Further Reading

→ 3 CENT Crypto to Explode December 16th? (From True Market Insiders) (Ad)

Should you invest $1,000 in Tiziana Life Sciences right now?

Before you consider Tiziana Life Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tiziana Life Sciences wasn't on the list.

While Tiziana Life Sciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Palo Alto Networks Gains Momentum: What’s Next for This Cybersecurity Giant?

Palo Alto Networks Gains Momentum: What’s Next for This Cybersecurity Giant?

With earnings on the horizon, will Palo Alto Networks continue its rally through Q4? Find out what analysts and investors are predicting.

Related Videos

3 Momentum Stock Picks With Room to Run

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines